These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 719904)

  • 21. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
    Thom MH; Collins WP; Studd JW
    Br J Obstet Gynaecol; 1981 Apr; 88(4):426-33. PubMed ID: 6784745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal profiles after the menopause.
    Chakravarti S; Collins WP; Forecast JD; Newton JR; Oram DH; Studd JW
    Br Med J; 1976 Oct; 2(6039):784-7. PubMed ID: 974609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A; Baraghini F; Barbieri C; Dalla Vecchia E; Previdi AM; Di Renzo GC; Volpe A
    Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
    Towobola OA; Crilly RC; Oakey RE
    Clin Endocrinol (Oxf); 1980 Nov; 13(5):461-71. PubMed ID: 6261992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogen modulation of gonadotrophin and prolactin release in women with anovulation and their responses to clomiphene.
    Kandeel FR; Butt WR; Rudd BT; Lynch SS; London DR; Edwards RL
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):619-35. PubMed ID: 383317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between climacteric symptoms and serum levels of estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone.
    Abe T; Furuhashi N; Yamaya Y; Wada Y; Hoshiai A; Suzuki M
    Am J Obstet Gynecol; 1977 Sep; 129(1):65-7. PubMed ID: 900171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silastic implants releasing estrone in the treatment of climacteric complaints.
    Sipinen S; Lähteenmäki P; Luukkainen T
    Maturitas; 1980 Oct; 2(3):213-24. PubMed ID: 6777635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
    Aedo AR; Sundén M; Landgren BM; Diczfalusy E
    Maturitas; 1989 Jun; 11(2):159-68. PubMed ID: 2547139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women.
    Wide L; Naessén T; Phillips DJ
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):59-64. PubMed ID: 7889633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raised plasma oestrogens in infertile men with elevated levels of FSH.
    Wu FC; Swanston IA; Baird DT
    Clin Endocrinol (Oxf); 1982 Jan; 16(1):39-47. PubMed ID: 6804135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
    Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
    Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of piperazine oestrone sulphate on serum lipids and lipoproteins in menopausal women.
    Isaacs AJ; Havard CW
    Acta Endocrinol (Copenh); 1977 May; 85(1):143-50. PubMed ID: 577072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption of percutaneous oestradiol in postmenopausal women.
    Sitruk-Ware R; de Lignieres B; Basdevant A; Mauvais-Jarvis P
    Maturitas; 1980 Oct; 2(3):207-11. PubMed ID: 6777634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of physiological changes in ovarian steroids on the prolactin response to gonadotrophin releasing factor.
    Tan YM; Steele PA; Judd SJ
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):71-8. PubMed ID: 3085991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of natural estrogen on the serum level of follicle-stimulating hormone (FSH), estradiol and estrone in post-menopausal women and its effect on endometrium.
    Varma TR; Everard D; Hole D
    Acta Obstet Gynecol Scand; 1985; 64(2):105-9. PubMed ID: 2984875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen and partial oestrogen agonism in postmenopausal women.
    Miodrag A; Ekelund P; Burton R; Castleden CM
    Age Ageing; 1991 Jan; 20(1):52-4. PubMed ID: 1903020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma oestrogens in postmenopausal women with endometrial cancer.
    Nyholm HC; Nielsen AL; Lyndrup J; Dreisler A; Hagen C; Haug E
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1115-9. PubMed ID: 8297845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.